52 North Health

The company develops in-vitro diagnostic and digital solutions to improve emergency care, specifically for oncology and nuclear preparedness. Its primary products include Neutrocheck, a portable finger-prick blood test for identifying neutropenic sepsis risk, and Aster, a platform for measuring cell-based and soluble biomarkers. These tools are designed for patients and healthcare professionals to enable remote triaging and management of emergency medical needs.